FDA Approved Drugs by Medical Condition

Search by medical condition for drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Select the letter below that corresponds to the first letter of the medical condition you are searching for and all approved drugs classified under that category will be listed below.

Fallopian Tube Cancer

Zejula (niraparib) (by Tesaro), Approved March 2017
For the treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer

Familial Hypercholesterolemia

Praluent (alirocumab) (by Sanofi Aventis), Approved July 2015
For the treatment of heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease

Repatha (evolocumab) (by Amgen), Approved August 2015
For the treatment of high cholesterol

Female Hormonal Deficiencies/Abnormalities

Addyi (flibanserin) (by Sprout Pharmaceuticals), Approved August 2015
For the treatment of premenopausal women with generalized hypoactive sexual desire disorder

Brisdelle (low-dose paroxetine mesylate) (by Noven Pharmaceuticals), Approved July 2013
For the treatment of vasomotor symptoms of menopause

Osphena (ospemifene) (by Shionogi), Approved March 2013
For the treatment of dyspareunia and vulvar and vaginal atrophy due to menopause

Follicular Lymphoma

Aliqopa (copanlisib) (by Bayer), Approved September 2017
For the treatment of follicular lymphoma

Zydelig (idelalisib) (by Gilead), Approved July 2014
For the treatment of relapsed CLL, follicular B-cell NHL and small lymphocytic lymphoma

Fungal Infections

Cancidas (by Merck), Approved January 2001
Intravenous infusion for the treatment of invasive aspergillosis

Cresemba (isavuconazonium sulfate) (by Astellas), Approved March 2015
For the treatment of invasive aspergillosis and invasive mucormycosis

Eraxis (anidulafungin) (by Pfizer), Approved February 2006
For the treatment of Candida fungal infections

Jublia (efinaconazole) 10% topical gel (by Valeant Pharmaceuticals), Approved June 2014
For the treatment of onychomycosis of the toenails

Kerydin (tavaborole) (by Anacor), Approved July 2014
For the treatment of onychomycosis of the toenails

Lamisil (terbinafine hydrochloride) Tablets (by Sandoz Pharmaceuticals), Approved May 1996
Treatment for nail fungal infections

Leukine (sargramostim) (by Immunex), Approved November 1996
Treatment for the replenishment of white blood cells

Luzu (luliconazole) Cream 1% (by Valeant Pharmaceuticals), November of 2013
For the treatment of interdigital tinea pedis, tinea cruris, and tinea corporis

Noxafil (posaconazole) (by Schering-Plough), Approved in September 2006
For the treatment of fungal infections

Vfend (voriconazole) (by Pfizer), Approved May 2002
For the treatment of fungal infections